Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects
Authors
Keywords
-
Journal
PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-04
DOI
10.1007/s00213-019-05363-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combining CDP-choline and galantamine, an optimized α7 nicotinic strategy, to ameliorate sensory gating to speech stimuli in schizophrenia
- (2019) Joelle Choueiry et al. INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY
- Physiological and neurobehavioral effects of cholinesterase inhibition in healthy adults
- (2015) Katherine C. Morasch et al. PHYSIOLOGY & BEHAVIOR
- A Test of the Cognitive Self-Medication Hypothesis of Tobacco Smoking in Schizophrenia
- (2013) Britta Hahn et al. BIOLOGICAL PSYCHIATRY
- Targeting alpha-7 nicotinic neurotransmission in schizophrenia: A novel agonist strategy
- (2013) Stephen I. Deutsch et al. SCHIZOPHRENIA RESEARCH
- Nicotinic acetylcholine receptors: From basic science to therapeutics
- (2012) Raymond Hurst et al. PHARMACOLOGY & THERAPEUTICS
- Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report
- (2012) Mehmet Sofuoglu et al. PSYCHOPHARMACOLOGY
- A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia
- (2011) Victoria C. Wing et al. Annals of the New York Academy of Sciences
- Positive allosteric modulators as an approach to nicotinic acetylcholine receptor-targeted therapeutics: Advantages and limitations
- (2011) Dustin K. Williams et al. BIOCHEMICAL PHARMACOLOGY
- Functional brain imaging of nicotinic effects on higher cognitive processes
- (2011) Paul A. Newhouse et al. BIOCHEMICAL PHARMACOLOGY
- ACHRNA5allele related to nicotine addiction and schizophrenia
- (2011) L. E. Hong et al. GENES BRAIN AND BEHAVIOR
- Drug targets for cognitive enhancement in neuropsychiatric disorders
- (2011) Tanya L. Wallace et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Selective nicotinic receptor antagonists: effects on attention and nicotine-induced attentional enhancement
- (2011) Britta Hahn et al. PSYCHOPHARMACOLOGY
- Neuronal Nicotinic Acetylcholine Receptors - Targets for the Development of Drugs to Treat Cognitive Impairment Associated with Schizophrenia and Alzheimers Disease
- (2010) Simon Haydar et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer’s disease assessed with positron emission tomography
- (2010) Kai Kendziorra et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Sensorimotor Gating is Associated with CHRNA3 Polymorphisms in Schizophrenia and Healthy Volunteers
- (2010) Nadine Petrovsky et al. NEUROPSYCHOPHARMACOLOGY
- Enhancement of Attentional Performance by Selective Stimulation of α4β2* nAChRs: Underlying Cholinergic Mechanisms
- (2010) William M Howe et al. NEUROPSYCHOPHARMACOLOGY
- Subtype-selective nicotinic agonists enhance olfactory working memory in normal rats: A novel use of the odour span task
- (2010) Samantha L. Rushforth et al. NEUROSCIENCE LETTERS
- Meta-analysis of the acute effects of nicotine and smoking on human performance
- (2010) Stephen J. Heishman et al. PSYCHOPHARMACOLOGY
- Structural and functional diversity of native brain neuronal nicotinic receptors
- (2009) Cecilia Gotti et al. BIOCHEMICAL PHARMACOLOGY
- Treating the Cognitive Deficits of Schizophrenia with Alpha4Beta2 Neuronal Nicotinic Receptor Agonists
- (2009) Richard Radek et al. CURRENT PHARMACEUTICAL DESIGN
- Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function
- (2009) Edson X. Albuquerque et al. PHYSIOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started